JP2016505044A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016505044A5 JP2016505044A5 JP2015553858A JP2015553858A JP2016505044A5 JP 2016505044 A5 JP2016505044 A5 JP 2016505044A5 JP 2015553858 A JP2015553858 A JP 2015553858A JP 2015553858 A JP2015553858 A JP 2015553858A JP 2016505044 A5 JP2016505044 A5 JP 2016505044A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- cyclodextrin
- compound
- nitroxyl donor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 20
- 229920000858 Cyclodextrin Polymers 0.000 claims 16
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical group O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims 14
- ZZRODMXZJNLQGD-UHFFFAOYSA-N ONS(=O)=O Chemical compound ONS(=O)=O ZZRODMXZJNLQGD-UHFFFAOYSA-N 0.000 claims 8
- 150000001875 compounds Chemical class 0.000 claims 8
- ODUCDPQEXGNKDN-UHFFFAOYSA-N nitroxyl Chemical compound O=N ODUCDPQEXGNKDN-UHFFFAOYSA-N 0.000 claims 8
- 239000000203 mixture Substances 0.000 claims 7
- NZAQRZWBQUIBSF-UHFFFAOYSA-N 4-(4-sulfobutoxy)butane-1-sulfonic acid Chemical class OS(=O)(=O)CCCCOCCCCS(O)(=O)=O NZAQRZWBQUIBSF-UHFFFAOYSA-N 0.000 claims 4
- 229960004853 betadex Drugs 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical group [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 claims 4
- 239000000872 buffer Substances 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 206010007556 Cardiac failure acute Diseases 0.000 claims 2
- 239000001116 FEMA 4028 Substances 0.000 claims 2
- 206010019280 Heart failures Diseases 0.000 claims 2
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims 2
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims 2
- 239000006172 buffering agent Substances 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 235000011056 potassium acetate Nutrition 0.000 claims 2
- 239000003381 stabilizer Substances 0.000 claims 2
- 208000024172 Cardiovascular disease Diseases 0.000 claims 1
- 239000012062 aqueous buffer Substances 0.000 claims 1
- 239000008057 potassium phosphate buffer Substances 0.000 claims 1
- 0 Cc1ccc(*)[o]1 Chemical compound Cc1ccc(*)[o]1 0.000 description 2
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361754237P | 2013-01-18 | 2013-01-18 | |
| US61/754,237 | 2013-01-18 | ||
| US201361782781P | 2013-03-14 | 2013-03-14 | |
| US61/782,781 | 2013-03-14 | ||
| PCT/US2014/012089 WO2014113700A1 (en) | 2013-01-18 | 2014-01-17 | Pharmaceutical compositions comprising nitroxyl donors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019096869A Division JP6801045B2 (ja) | 2013-01-18 | 2019-05-23 | ニトロキシル供与体を含む医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016505044A JP2016505044A (ja) | 2016-02-18 |
| JP2016505044A5 true JP2016505044A5 (enExample) | 2017-02-23 |
| JP6533159B2 JP6533159B2 (ja) | 2019-06-19 |
Family
ID=50064795
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015553858A Expired - Fee Related JP6533159B2 (ja) | 2013-01-18 | 2014-01-17 | ニトロキシル供与体を含む医薬組成物 |
| JP2015553856A Expired - Fee Related JP6449171B2 (ja) | 2013-01-18 | 2014-01-17 | 治療指数の改善されたニトロキシル供与体 |
| JP2017005276A Expired - Fee Related JP6311038B2 (ja) | 2013-01-18 | 2017-01-16 | 治療指数の改善されたニトロキシル供与体 |
| JP2018228317A Active JP6656345B2 (ja) | 2013-01-18 | 2018-12-05 | 治療指数の改善されたニトロキシル供与体 |
| JP2019096869A Expired - Fee Related JP6801045B2 (ja) | 2013-01-18 | 2019-05-23 | ニトロキシル供与体を含む医薬組成物 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015553856A Expired - Fee Related JP6449171B2 (ja) | 2013-01-18 | 2014-01-17 | 治療指数の改善されたニトロキシル供与体 |
| JP2017005276A Expired - Fee Related JP6311038B2 (ja) | 2013-01-18 | 2017-01-16 | 治療指数の改善されたニトロキシル供与体 |
| JP2018228317A Active JP6656345B2 (ja) | 2013-01-18 | 2018-12-05 | 治療指数の改善されたニトロキシル供与体 |
| JP2019096869A Expired - Fee Related JP6801045B2 (ja) | 2013-01-18 | 2019-05-23 | ニトロキシル供与体を含む医薬組成物 |
Country Status (29)
| Country | Link |
|---|---|
| US (13) | US10245249B2 (enExample) |
| EP (5) | EP3567031A1 (enExample) |
| JP (5) | JP6533159B2 (enExample) |
| KR (2) | KR102177899B1 (enExample) |
| CN (4) | CN105142627B (enExample) |
| AU (5) | AU2014207408C1 (enExample) |
| BR (2) | BR112015017241B1 (enExample) |
| CA (2) | CA2898443C (enExample) |
| CY (3) | CY1120535T1 (enExample) |
| DK (3) | DK2945621T3 (enExample) |
| ES (4) | ES2882279T3 (enExample) |
| HK (1) | HK1251170B (enExample) |
| HR (3) | HRP20182144T1 (enExample) |
| HU (3) | HUE041861T2 (enExample) |
| IL (4) | IL239906B (enExample) |
| LT (3) | LT2945621T (enExample) |
| MX (2) | MX373176B (enExample) |
| NZ (4) | NZ709986A (enExample) |
| PL (3) | PL2945621T3 (enExample) |
| PT (3) | PT2945621T (enExample) |
| RS (3) | RS59434B1 (enExample) |
| RU (3) | RU2684916C2 (enExample) |
| SG (6) | SG10201913286PA (enExample) |
| SI (3) | SI2945620T1 (enExample) |
| SM (3) | SMT201900027T1 (enExample) |
| TR (1) | TR201802211T4 (enExample) |
| TW (3) | TWI619491B (enExample) |
| WO (2) | WO2014113700A1 (enExample) |
| ZA (2) | ZA201505090B (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2489350E (pt) | 2006-03-17 | 2014-03-10 | Univ Johns Hopkins Med | Derivados de n-hidroxilsulfonamida como novos dadores de nitroxilo fisiologicamente úteis |
| CN108409662B (zh) | 2011-10-17 | 2021-10-26 | 约翰斯霍普金斯大学 | 作为hno供体的经羟胺取代的米氏酸、巴比妥酸和吡唑啉酮衍生物 |
| NZ709986A (en) | 2013-01-18 | 2020-01-31 | Cardioxyl Pharmaceuticals Inc | Pharmaceutical compositions comprising nitroxyl donors |
| WO2015109210A1 (en) | 2014-01-17 | 2015-07-23 | Cardioxyl Pharmaceuticals, Inc. | N-hydroxymethanesulfonamide nitroxyl donors |
| US9464061B2 (en) | 2014-05-27 | 2016-10-11 | The Johns Hopkins University | N-hydroxylamino-barbituric acid derivatives |
| US9682938B2 (en) | 2014-05-27 | 2017-06-20 | Cardioxyl Pharmaceuticals, Inc. | Pyrazolone derivatives as nitroxyl donors |
| JP2018526448A (ja) | 2015-09-07 | 2018-09-13 | 浙江華海薬業股▲フン▼有限公司 | 一酸化窒素を放出可能なプロドラッグ分子 |
| EP3365325A1 (en) | 2015-10-19 | 2018-08-29 | Cardioxyl Pharmaceuticals Inc. | N-hydroxylsulfonamide derivatives as nitroxyl donors |
| JP6889704B2 (ja) | 2015-10-19 | 2021-06-18 | カルディオキシル ファーマシューティカルズ，インク． | ニトロキシルドナーとしてのピラゾロン誘導体 |
| JP7194436B2 (ja) | 2016-07-28 | 2022-12-22 | ザ ジョンズ ホプキンス ユニバーシティ | Ｏ－置換ヒドロキサム酸 |
| CN110520116A (zh) | 2017-01-03 | 2019-11-29 | 卡尔迪奥克斯尔制药公司 | 供硝酰化合物的给予方法 |
| KR102699958B1 (ko) * | 2017-04-18 | 2024-08-29 | 장피트 | 엘라피브라노르와 같은 ppar 작용제 및 아세틸-coa 카르복실라아제 (acc) 저해제를 포함하는 조합 |
| CN116283762B (zh) * | 2023-03-28 | 2025-08-12 | 昆山市第一人民医院 | 一种用于制备白鲜碱的中间体化合物及其制备方法、白鲜碱的制备方法 |
| WO2025043108A1 (en) * | 2023-08-23 | 2025-02-27 | Bristol -Myers S Quibb Company | Co-crystals of nitroxyl donating compounds |
Family Cites Families (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1017976A (en) | 1911-08-25 | 1912-02-20 | Rudolph Koch | Automatic mail-bag catcher and deliverer. |
| US1021340A (en) | 1911-10-14 | 1912-03-26 | William A Scott | Means for attaching binding-posts to dry batteries. |
| US3751255A (en) | 1972-03-24 | 1973-08-07 | Eastman Kodak Co | Photosensitive and thermosensitive element, composition and process |
| JPS567710A (en) | 1979-06-28 | 1981-01-27 | Sansho Seiyaku Kk | Whitening cosmetic |
| US4539321A (en) | 1981-10-26 | 1985-09-03 | William H. Rorer, Inc. | 5-Diaza-aryl-3-substituted pyridone compounds |
| EP0188040B1 (en) | 1985-01-11 | 1991-08-14 | Abbott Laboratories Limited | Slow release solid preparation |
| US4663351A (en) | 1985-08-23 | 1987-05-05 | Berlex Laboratories, Inc. | Dobutamine tri-isobutyric acid ester and the use thereof as a cardiotonic agent |
| US4798824A (en) | 1985-10-03 | 1989-01-17 | Wisconsin Alumni Research Foundation | Perfusate for the preservation of organs |
| JPH01221371A (ja) | 1988-02-29 | 1989-09-04 | Hokko Chem Ind Co Ltd | 環状オキシアミン誘導体の製造方法 |
| JPH01221372A (ja) | 1988-03-01 | 1989-09-04 | Hokko Chem Ind Co Ltd | 環状アシルヒドロキシルアミン誘導体 |
| JPH0221372A (ja) | 1988-07-08 | 1990-01-24 | Sharp Corp | はんだ付検査装置 |
| JPH0828240B2 (ja) | 1990-05-25 | 1996-03-21 | 矢崎総業株式会社 | 電線相互の圧着接続構造及び圧着接続方法 |
| JP2773959B2 (ja) | 1990-07-10 | 1998-07-09 | 信越化学工業株式会社 | 大腸内放出性固形製剤 |
| JPH04321671A (ja) | 1991-04-17 | 1992-11-11 | Mitsubishi Petrochem Co Ltd | カルバモイルトリアゾール誘導体およびそれを有効成分とする除草剤 |
| CN1143950A (zh) * | 1994-01-19 | 1997-02-26 | 比克荷兰有限公司 | 含硝酰基的苄胺衍生物及其在治疗心血管疾病和治疗升高眼压中的应用 |
| US6156728A (en) * | 1996-11-01 | 2000-12-05 | Genentech, Inc. | Treatment of inner ear hair cells |
| JPH10142729A (ja) | 1996-11-05 | 1998-05-29 | Fuji Photo Film Co Ltd | 熱現像画像記録材料 |
| US6525081B1 (en) | 1997-10-24 | 2003-02-25 | Shionogi & Co., Ltd. | Antirheumatic |
| SI0930302T1 (en) | 1998-01-16 | 2003-10-31 | F. Hoffmann-La Roche Ag | Benzosulfone derivatives |
| WO1999063385A1 (en) | 1998-06-04 | 1999-12-09 | Board Of Regents, The University Of Texas System | Digital optical chemistry micromirror imager |
| UA73092C2 (uk) | 1998-07-17 | 2005-06-15 | Брістол-Майерс Сквібб Компані | Таблетка з ентеросолюбільним покриттям і спосіб її приготування |
| CA2338780C (en) | 1998-07-28 | 2007-01-02 | Tanabe Seiyaku Co., Ltd. | Preparation capable of releasing medicinal substance at targeted site in intestine |
| GB9918684D0 (en) | 1999-08-09 | 1999-10-13 | Novartis Ag | Organic compounds |
| JP2002072459A (ja) | 2000-08-28 | 2002-03-12 | Toyo Gosei Kogyo Kk | 光酸発生剤及びそれを含有する感光性樹脂組成物 |
| WO2002057252A2 (en) | 2000-12-13 | 2002-07-25 | Wyeth | Heterocyclic sulfonamide inhibitors of beta amyloid production |
| EP1219306A1 (en) * | 2000-12-29 | 2002-07-03 | Nicox S.A. | Compositions comprising cyclodextrins and NO- releasing drugs |
| GB0114223D0 (en) | 2001-06-12 | 2001-08-01 | Ici Plc | Catalytic oxidation process |
| US20040038947A1 (en) | 2002-06-14 | 2004-02-26 | The Gov. Of The U.S. Of America As Represented By The Sec. Of The Dept. Of Health & Human Services | Method of treating ischemia/reperfusion injury with nitroxyl donors |
| US6936639B2 (en) | 2002-08-21 | 2005-08-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Nitroxyl progenitors in the treatment of heart failure |
| US7572914B2 (en) | 2003-12-19 | 2009-08-11 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
| WO2005074598A2 (en) | 2004-01-30 | 2005-08-18 | Johns Hopkins University | Nitroxyl progenitor compounds and methods of use |
| WO2006043965A1 (en) | 2004-10-14 | 2006-04-27 | Allergan, Inc. | Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods |
| EP1846439A2 (en) | 2005-01-31 | 2007-10-24 | The Johns Hopkins University | Use of consensus sequence as vaccine antigen to enhance recognition of virulent viral variants |
| CA2613477C (en) | 2005-06-23 | 2013-12-03 | Johns Hopkins University | Thiol-sensitive positive inotropes |
| PT2489350E (pt) | 2006-03-17 | 2014-03-10 | Univ Johns Hopkins Med | Derivados de n-hidroxilsulfonamida como novos dadores de nitroxilo fisiologicamente úteis |
| JP2009533457A (ja) | 2006-04-13 | 2009-09-17 | ウェイク・フォレスト・ユニヴァーシティ・ヘルス・サイエンシズ | Ｃ−ニトロソから誘導されるニトロキシル供与体 |
| RU2485097C2 (ru) | 2007-09-26 | 2013-06-20 | Джонс Хопкинс Юниверсити | Производные n-гидроксилсульфонамида как новые физиологически применимые доноры нитроксила |
| HRP20161205T1 (hr) | 2008-05-07 | 2016-11-18 | Cardioxyl Pharmaceuticals Inc. | Novi nitrozo spojevi kao donori nitroksila i metode za njihovu upotrebu |
| US20110160200A1 (en) | 2009-11-23 | 2011-06-30 | Cardioxyl Pharmaceuticals, Inc. | Nitroxyl Progenitors for the Treatment of Pulmonary Hypertension |
| AU2010328234B2 (en) | 2009-12-07 | 2016-05-12 | Cardioxyl Pharmaceuticals, Inc. | N-acyloxysulfonamide and N-hydroxy-N-acylsulfonamide derivatives |
| AU2010328230B2 (en) | 2009-12-07 | 2016-06-02 | Cardioxyl Pharmaceuticals, Inc. | Bis-acylated hydroxylamine derivatives |
| CN108409662B (zh) | 2011-10-17 | 2021-10-26 | 约翰斯霍普金斯大学 | 作为hno供体的经羟胺取代的米氏酸、巴比妥酸和吡唑啉酮衍生物 |
| JP6306602B2 (ja) | 2012-11-01 | 2018-04-04 | ザ ジョンズ ホプキンス ユニバーシティ | 分子内環化−脱離による制御されたｈｎｏ放出 |
| NZ709986A (en) | 2013-01-18 | 2020-01-31 | Cardioxyl Pharmaceuticals Inc | Pharmaceutical compositions comprising nitroxyl donors |
| WO2015109210A1 (en) | 2014-01-17 | 2015-07-23 | Cardioxyl Pharmaceuticals, Inc. | N-hydroxymethanesulfonamide nitroxyl donors |
| US9464061B2 (en) | 2014-05-27 | 2016-10-11 | The Johns Hopkins University | N-hydroxylamino-barbituric acid derivatives |
-
2014
- 2014-01-17 NZ NZ709986A patent/NZ709986A/en unknown
- 2014-01-17 SG SG10201913286PA patent/SG10201913286PA/en unknown
- 2014-01-17 PL PL14703010T patent/PL2945621T3/pl unknown
- 2014-01-17 ES ES18190818T patent/ES2882279T3/es active Active
- 2014-01-17 EP EP19181338.5A patent/EP3567031A1/en not_active Withdrawn
- 2014-01-17 TW TW103101912A patent/TWI619491B/zh not_active IP Right Cessation
- 2014-01-17 SM SM20190027T patent/SMT201900027T1/it unknown
- 2014-01-17 TW TW103101913A patent/TWI686193B/zh active
- 2014-01-17 RU RU2015134583A patent/RU2684916C2/ru active
- 2014-01-17 SG SG10201913441RA patent/SG10201913441RA/en unknown
- 2014-01-17 PT PT14703010T patent/PT2945621T/pt unknown
- 2014-01-17 HR HRP20182144TT patent/HRP20182144T1/hr unknown
- 2014-01-17 HU HUE14703010A patent/HUE041861T2/hu unknown
- 2014-01-17 SI SI201430507T patent/SI2945620T1/en unknown
- 2014-01-17 WO PCT/US2014/012089 patent/WO2014113700A1/en not_active Ceased
- 2014-01-17 LT LTEP14703010.0T patent/LT2945621T/lt unknown
- 2014-01-17 DK DK14703010.0T patent/DK2945621T3/en active
- 2014-01-17 DK DK17195759T patent/DK3284463T3/da active
- 2014-01-17 SI SI201431361T patent/SI3284463T1/sl unknown
- 2014-01-17 ES ES14703010T patent/ES2705240T3/es active Active
- 2014-01-17 BR BR112015017241-5A patent/BR112015017241B1/pt active IP Right Grant
- 2014-01-17 MX MX2015009276A patent/MX373176B/es active IP Right Grant
- 2014-01-17 SG SG11201505567RA patent/SG11201505567RA/en unknown
- 2014-01-17 NZ NZ709985A patent/NZ709985A/en unknown
- 2014-01-17 RU RU2018143994A patent/RU2018143994A/ru unknown
- 2014-01-17 KR KR1020157022200A patent/KR102177899B1/ko not_active Expired - Fee Related
- 2014-01-17 SG SG10201802862WA patent/SG10201802862WA/en unknown
- 2014-01-17 PT PT171957590T patent/PT3284463T/pt unknown
- 2014-01-17 RS RSP20191352 patent/RS59434B1/sr unknown
- 2014-01-17 MX MX2015009269A patent/MX363843B/es active IP Right Grant
- 2014-01-17 CN CN201480013223.XA patent/CN105142627B/zh active Active
- 2014-01-17 PL PL17195759T patent/PL3284463T3/pl unknown
- 2014-01-17 JP JP2015553858A patent/JP6533159B2/ja not_active Expired - Fee Related
- 2014-01-17 NZ NZ748769A patent/NZ748769A/en unknown
- 2014-01-17 CA CA2898443A patent/CA2898443C/en active Active
- 2014-01-17 NZ NZ748771A patent/NZ748771A/en unknown
- 2014-01-17 EP EP18190818.7A patent/EP3427728B1/en active Active
- 2014-01-17 HU HUE17195759A patent/HUE046722T2/hu unknown
- 2014-01-17 ES ES14703009.2T patent/ES2659969T3/es active Active
- 2014-01-17 LT LTEP14703009.2T patent/LT2945620T/lt unknown
- 2014-01-17 HU HUE14703009A patent/HUE036589T2/hu unknown
- 2014-01-17 PT PT147030092T patent/PT2945620T/pt unknown
- 2014-01-17 CA CA2898445A patent/CA2898445C/en active Active
- 2014-01-17 KR KR1020157022192A patent/KR102277165B1/ko active Active
- 2014-01-17 EP EP17195759.0A patent/EP3284463B1/en active Active
- 2014-01-17 EP EP14703009.2A patent/EP2945620B1/en active Active
- 2014-01-17 WO PCT/US2014/012085 patent/WO2014113696A1/en not_active Ceased
- 2014-01-17 BR BR112015017251-2A patent/BR112015017251B1/pt active IP Right Grant
- 2014-01-17 TR TR2018/02211T patent/TR201802211T4/tr unknown
- 2014-01-17 AU AU2014207408A patent/AU2014207408C1/en active Active
- 2014-01-17 CN CN201810074807.8A patent/CN108610312A/zh active Pending
- 2014-01-17 EP EP14703010.0A patent/EP2945621B1/en active Active
- 2014-01-17 AU AU2014207404A patent/AU2014207404B2/en active Active
- 2014-01-17 RS RS20181599A patent/RS58174B1/sr unknown
- 2014-01-17 RU RU2015134581A patent/RU2676277C2/ru active
- 2014-01-17 CN CN201480013565.1A patent/CN105073105B/zh active Active
- 2014-01-17 US US14/761,934 patent/US10245249B2/en active Active
- 2014-01-17 TW TW107143952A patent/TWI712409B/zh not_active IP Right Cessation
- 2014-01-17 ES ES17195759T patent/ES2751922T3/es active Active
- 2014-01-17 SG SG10201802855TA patent/SG10201802855TA/en unknown
- 2014-01-17 LT LT17195759T patent/LT3284463T/lt unknown
- 2014-01-17 RS RS20180099A patent/RS56968B1/sr unknown
- 2014-01-17 US US14/158,456 patent/US8987326B2/en active Active
- 2014-01-17 SG SG11201505568PA patent/SG11201505568PA/en unknown
- 2014-01-17 SI SI201430983T patent/SI2945621T1/sl unknown
- 2014-01-17 JP JP2015553856A patent/JP6449171B2/ja not_active Expired - Fee Related
- 2014-01-17 CN CN201910446030.8A patent/CN110179777B/zh active Active
- 2014-01-17 PL PL14703009T patent/PL2945620T3/pl unknown
- 2014-01-17 HR HRP20180121TT patent/HRP20180121T1/hr unknown
- 2014-01-17 SM SM20190575T patent/SMT201900575T1/it unknown
- 2014-01-17 SM SM20180088T patent/SMT201800088T1/it unknown
- 2014-01-17 DK DK14703009.2T patent/DK2945620T3/en active
-
2015
- 2015-03-07 US US14/641,377 patent/US9156804B2/en active Active
- 2015-07-13 IL IL239906A patent/IL239906B/en active IP Right Grant
- 2015-07-15 ZA ZA2015/05090A patent/ZA201505090B/en unknown
- 2015-07-15 IL IL239952A patent/IL239952B/en active IP Right Grant
- 2015-10-09 US US14/880,173 patent/US9586896B2/en active Active
-
2016
- 2016-07-07 ZA ZA2016/04798A patent/ZA201604798B/en unknown
-
2017
- 2017-01-10 AU AU2017200147A patent/AU2017200147B2/en active Active
- 2017-01-16 JP JP2017005276A patent/JP6311038B2/ja not_active Expired - Fee Related
- 2017-02-13 US US15/430,946 patent/US9968584B2/en active Active
-
2018
- 2018-01-12 CY CY20181100038T patent/CY1120535T1/el unknown
- 2018-04-23 IL IL258882A patent/IL258882A/en active IP Right Grant
- 2018-04-24 US US15/960,993 patent/US10213408B2/en active Active
- 2018-05-09 IL IL25923318A patent/IL259233B/en active IP Right Grant
- 2018-05-09 AU AU2018203240A patent/AU2018203240B2/en active Active
- 2018-08-20 HK HK18110676.0A patent/HK1251170B/en unknown
- 2018-10-05 AU AU2018241168A patent/AU2018241168B2/en active Active
- 2018-12-05 JP JP2018228317A patent/JP6656345B2/ja active Active
-
2019
- 2019-01-08 US US16/242,139 patent/US10517847B2/en active Active
- 2019-01-15 CY CY20191100046T patent/CY1121480T1/el unknown
- 2019-03-29 US US16/370,443 patent/US10548872B2/en active Active
- 2019-05-23 JP JP2019096869A patent/JP6801045B2/ja not_active Expired - Fee Related
- 2019-10-16 CY CY20191101084T patent/CY1122177T1/el unknown
- 2019-10-23 HR HRP20191919TT patent/HRP20191919T8/hr unknown
- 2019-12-23 US US16/724,657 patent/US10792273B2/en active Active
-
2020
- 2020-01-31 US US16/779,015 patent/US11304924B2/en active Active
- 2020-10-05 US US17/063,372 patent/US11273143B2/en active Active
-
2022
- 2022-03-14 US US17/694,500 patent/US11786501B2/en active Active
-
2023
- 2023-09-22 US US18/371,722 patent/US12186301B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016505044A5 (enExample) | ||
| CY1123391T1 (el) | (2s)-n-[(1s)-1-kyano-2-φainyλaιθyλ]-1,4-oξazeπan-2-καρβοξαμιδια ως αναστολεις της διπεπτιδυλικης πεπτιδασης ι | |
| CL2017000379A1 (es) | Compuestos de pirrolopirimidina usados como agonistas del receptor de tipo toll. 7 (tlr7) | |
| BR112016005270A2 (pt) | compostos de aza-piridona, composições farmacêuticas e seus usos | |
| JP2017537066A5 (enExample) | ||
| TN2017000467A1 (en) | Amido-substituted cyclohexane derivatives | |
| RU2015134583A (ru) | Фармацевтические композиции, содержащие доноры нитроксила | |
| JP2015057437A5 (enExample) | ||
| JP2016513069A5 (enExample) | ||
| CY1118682T1 (el) | Ενωσεις πυραζολης ως αναστολεις του υποδοχεα σιγμα | |
| CY1113819T1 (el) | Σκευασματα για τη θεραπευτικη αντιμετωπιση του καρκινου | |
| JP2016130266A5 (enExample) | ||
| JP2016510019A5 (enExample) | ||
| CY1125179T1 (el) | Παραγωγα πυραζολιου χρησιμα ως αναστολεις της πρωτεïνης ενεργοποιησης της 5-λιποξυγενασης (flap) | |
| JP2015512432A5 (enExample) | ||
| BR112018013033A2 (pt) | compostos de indolinonas e seu uso no tratamentod de doenças fibróticas | |
| JP2017515840A5 (enExample) | ||
| JOP20200100A1 (ar) | مشتقات بيرازولو-بيرولو-بيريميدين-ديون جديدة كمثبِّطات لـ p2x3 | |
| CN109922806A (zh) | 氢溴酸沃替西汀长效注射制剂 | |
| CN109310676A (zh) | 一种苯酚衍生物和依托咪酯的药物组合物、药物制剂及其用途 | |
| JP2017226652A5 (enExample) | ||
| CN115379827A (zh) | 苯达莫司汀组合物及其用途 | |
| JP2016534062A5 (enExample) | ||
| JP2016508138A5 (enExample) | ||
| MX2017015192A (es) | Derivado de bisamida de acido dicarboxilico como agente que estimula regeneracion de tejidos y recuperacion de funcion tisular disminuida. |